Nurix Therapeutics, Inc. logo NRIX - Nurix Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 17
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $32.20 DETAILS
HIGH: $36.00
LOW: $28.00
MEDIAN: $32.00
CONSENSUS: $32.20
UPSIDE: 84.00%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Revenue
Revenue 6.3 13.6 7.9 44.1 18.5 13.3 12.6 12.1 16.6 15.2 18.5 30.7 12.7 6.8 10.8 11.4 9.6 7.4 10.3 7.1 5.0 6.7 4.1 4.2 2.9 1.9 10.6 9.4 9.2
Cost of Revenue 84.1 4.6 5 78.1 69.7 67.2 55.5 48.9 50.0 49.7 47.9 45.8 45.8 46.1 47.8 47.5 43.1 36.5 30.9 26.0 23.0 20.4 18.9 14.1 13.0 12.8 11.0 10.8 10.4
Gross Profit (77.9) 8.9 2.9 (34.0) (51.2) (53.9) (42.9) (36.8) (33.4) (34.6) (29.4) (15.1) (33.1) (39.3) (37.0) (36.1) (33.5) (29.1) (20.7) (18.9) (18.0) (13.8) (14.9) (10.0) (10.1) (11.0) (0.4) (1.3) (1.2)
Operating Expenses
R&D Expenses 0 80.9 86.1 78.1 69.7 67.2 55.5 48.9 50.0 49.7 47.9 45.8 45.8 46.1 47.8 47.5 43.1 36.5 30.9 26.0 23.0 20.4 18.9 14.1 13.0 12.8 11.0 10.8 10.4
SG&A Expenses 14.6 13.6 13.2 14.3 11.7 10.7 11.7 11.7 11.8 10.8 10.6 11.7 9.8 9.4 9.7 9.7 9.2 8.8 8.3 7.5 6.5 6.3 4.3 3.3 2.5 2.6 2.2 1.9 1.7
Other Expenses 0 (2.5) (5) (78.1) (69.7) (67.2) (55.5) (48.9) (50.0) (49.7) (47.9) (45.8) (45.8) (46.1) (47.8) (47.5) (43.1) (36.5) (30.9) (26.0) (23.0) (20.4) (18.9) (14.1) (13.0) (12.8) (11.0) (10.8) (10.4)
Operating Expenses 14.6 92.0 94.3 14.3 11.7 10.7 11.7 11.7 11.8 10.8 10.6 11.7 9.8 9.4 9.7 9.7 9.2 8.8 8.3 7.5 6.5 6.3 4.3 3.3 2.5 2.6 2.2 1.9 1.7
Operating Income
Operating Income (92.5) (83.1) (91.4) (48.3) (62.9) (64.7) (54.6) (48.5) (45.2) (45.3) (40.0) (26.8) (43.0) (48.7) (46.7) (45.7) (42.7) (38.0) (29.0) (26.4) (24.5) (20.0) (19.2) (13.2) (12.6) (13.6) (2.6) (3.2) (2.9)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 0 4.9 5.0 5.6 6.5 6.1 5.7 4.1 3.8 3.4 3.0 2.5 2.2 2.0 1.0 0.3 0.2 0.3 0.0 0.2 0.3 0.1 0.7 0.2 0.2 0.3 0.2 0.1 0.2
Profitability
EBITDA (92.5) (69.0) (81.4) (46.1) (60.5) (63.4) (52.2) (46.2) (43.2) (44.8) (38.1) (24.9) (41.2) (48.3) (45.3) (44.4) (41.8) (37.2) (28.3) (25.8) (23.9) (19.4) (18.6) (12.7) (12.1) (13.0) (2.1) (2.6) (2.2)
EBIT (92.5) (78.2) (86.4) (48.3) (62.9) (64.7) (54.6) (48.5) (45.2) (45.3) (40.0) (26.8) (43.0) (48.7) (46.7) (45.7) (42.7) (38.0) (29.0) (26.4) (24.5) (20.0) (19.2) (13.2) (12.6) (13.6) (2.6) (3.2) (2.9)
Income Before Tax (87.2) (78.2) (86.4) (42.7) (56.4) (58.5) (48.9) (44.5) (41.4) (42.0) (37.0) (24.3) (40.7) (46.7) (45.7) (45.4) (42.5) (37.7) (29.0) (26.2) (24.2) (19.9) (18.5) (13.0) (12.4) (13.3) (2.4) (3.1) (2.7)
Income Tax Expense 0 0 0 0.8 0 0.0 0.1 0.1 0.1 0 0 0 0 0 0 0 0 0.0 (0.1) 0.1 0.1 0.0 0 (20.6) 0.0 0.2 0.0 0.0 0.0
Net Income (87.2) (78.2) (86.4) (43.5) (56.4) (58.5) (49.0) (44.5) (41.5) (42.0) (37.0) (24.3) (40.7) (46.7) (45.7) (45.4) (42.5) (37.7) (28.8) (26.4) (24.3) (19.9) (18.5) 7.6 (12.4) (13.5) (2.4) (3.1) (2.7)
Per Share Data
EPS (Basic) -0.79 -0.82 -1.03 -0.52 -0.67 -0.75 -0.67 -0.71 -0.76 -0.77 -0.68 -0.40 -0.65 -0.77 -0.88 -1.00 -0.95 -0.85 -0.65 -0.60 -0.63 -0.51 -1.09 0.22 -0.60 -0.65 -0.12 -0.94 -0.85
EPS (Diluted) -0.79 -0.82 -1.03 -0.52 -0.67 -0.75 -0.67 -0.71 -0.76 -0.77 -0.68 -0.40 -0.65 -0.77 -0.88 -1.00 -0.95 -0.85 -0.65 -0.60 -0.63 -0.51 -1.09 0.22 -0.60 -0.65 -0.12 -0.94 -0.85
Shares Outstanding 110.1 95.1 84.2 83.9 83.6 78.4 72.8 62.4 54.9 54.7 54.4 54.3 54.0 53.9 50.9 44.9 44.7 44.6 44.4 43.8 38.8 38.7 16.9 34.8 20.8 20.8 20.8 3.2 3.1
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q1
Current Assets
Cash & Cash Equivalents 71.2 247.0 78.4 84.3 75.9 110.0 99.0 116.8 49.8 54.6 42.3 59.0 33.6 64.5 47.6 41.5 78.8 80.5 147.4 188.2 126.4 119.4 265.5 159.3 56.4 34.8 (39.0)
Short-Term Investments 469.5 346.0 350.4 401.5 473.8 499.6 349.0 326.3 194.2 233.3 216.5 222.2 243.6 244.7 296.9 255.7 183.2 215.2 196.5 197.8 176.7 161.8 88.7 14.2 14.9 2.9 78.1
Net Receivables 2.4 0 0 19 0 1.5 0.8 0.6 0.8 0.8 2 0 0 0 0 0 9.1 6.2 5.2 5.7 4.0 11.3 3.9 19.6 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 (1) (1.2) (1.1) (1.1) (0.7) 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 11.3 13.9 11.8 10.5 14.0 8.3 7.2 6.5 6.2 6.8 7.1 8.8 11.2 9.3 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Current Assets 554.4 606.8 440.6 515.3 563.7 619.4 456.0 450.2 251.0 295.5 267.9 290.0 288.3 318.4 354.9 306.8 280.5 311.1 358.4 396.3 310.8 298.4 364.1 196.8 76.7 39.4 39.0
Non-Current Assets
Property, Plant & Equipment 73.4 73.0 73.5 69.0 44.8 45.9 44.2 47.4 47.2 48.0 25.6 28.4 28.6 29.5 30.3 30.9 29.4 25.3 9.6 8.3 7.0 6.7 6.5 5.8 4.0 3.9 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 9.5 10.3 11.2 7.4 9.9 27.5 48.4 63.9 69.1 51.5 123.7 137.5 121.5 110.4 77.2 90.9 40.9 9.1 7.6 0.5 0
Other Non-Current Assets 8.4 8.3 8.3 7.2 6.5 4.1 3.9 3.1 3.3 4.7 4.8 4.7 4.7 4.9 5.0 5.1 4.2 3.1 3.6 2.9 1.7 0.3 0.4 1.6 0.6 0.3 (39.0)
Total Non-Current Assets 81.7 81.3 81.9 76.2 51.3 50.0 57.6 60.8 61.7 60.1 40.2 60.6 81.8 98.3 104.5 87.5 157.2 165.7 134.6 121.7 85.9 97.9 47.8 16.5 12.1 4.7 (39.0)
Total Assets 636.1 688.1 522.5 591.6 615.0 669.3 513.6 511.0 312.7 355.6 308.2 350.6 370.2 416.8 459.3 394.3 437.7 476.8 493.1 518.0 396.7 396.3 411.9 213.3 88.8 44.0 0
Current Liabilities
Account Payables 10.3 11.2 8.6 6.0 8.4 11.5 3.9 2.8 5.9 6.4 2.2 4.5 5.6 5.1 6.1 6.1 6.0 6.7 3.9 5.4 4.4 3.4 3.6 4.9 2.1 1.6 0
Short-Term Debt 0 0 0 0 0 0 0 7.9 7.3 7.5 0 5.6 5.6 5.5 5.5 5.5 5.4 3.8 0 0 0 0 0 0 0 0 0
Deferred Revenue 18.8 17.6 26.0 27.4 30.6 38.4 48.0 46.8 46.1 48.1 32.0 44.1 38.3 37.6 36.3 41.3 43.2 41.2 35.2 33.8 32.8 32.8 30.3 25.4 21.4 9.6 0
Other Current Liabilities 33.0 23.6 18.1 13.6 22.6 18.9 15.2 13.4 17.5 0.8 12.4 10.3 8.6 14.7 12.0 11.9 7.4 5.7 5.5 2.7 3.2 2.6 3.3 1.6 1.8 1.2 0
Total Current Liabilities 92.2 86.5 82.3 75.6 90.0 95.9 86.3 80.8 87.6 87.0 61.5 72.3 64.9 70.7 67.5 72.7 66.0 66.3 50.7 46.8 48.0 44.5 41.0 34.4 30.0 16.1 0
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 48.2 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0.8 0.8 0.8 0.9 0.9 1.8 1.7 0
Total Non-Current Liabilities 63.0 62.9 67.9 68.3 44.1 46.5 50.4 59.6 56.3 68.1 12.9 18.4 31.2 42.4 49.3 54.9 65.8 68.2 67.2 73.0 78.6 61.5 63.2 72.3 128.6 85.6 0
Total Liabilities 155.2 149.4 150.2 144.0 134.1 142.3 136.7 140.3 143.9 155.1 74.4 90.7 96.1 113.1 116.8 127.6 131.8 134.5 117.9 119.8 126.5 106.1 104.3 106.7 158.6 53.6 0
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (1,090.4) (1,003.2) (925.0) (838.6) (795.1) (738.8) (680.2) (631.3) (586.7) (545.2) (503.2) (466.3) (442.0) (401.3) (354.5) (308.8) (263.4) (220.9) (183.2) (154.4) (128.0) (103.7) (83.8) (65.3) (72.8) (60.5) 0
Accumulated Other Comprehensive Income 0.1 0.1 0.1 (0.0) 0.2 0.1 0.3 (0.1) (0.3) (0.7) (1.2) (1.9) (3.2) (4.3) (3.7) (3.1) (2.1) (0.6) (0.1) 0.0 0.0 0.1 0.1 0.1 0.1 (0.0) (36.8)
Total Stockholders' Equity 480.9 538.7 372.3 447.6 480.9 527.0 376.9 370.7 168.7 200.5 233.8 259.9 274.1 303.7 342.5 266.7 305.9 342.3 375.2 398.2 270.1 290.3 307.6 106.6 (69.8) (57.7) 11.3
Total Liabilities & Equity 636.1 688.1 522.5 591.6 615.0 669.3 513.6 511.0 312.7 355.6 308.2 350.6 370.2 416.8 459.3 394.3 437.7 476.8 493.1 518.0 396.7 396.3 411.9 213.3 88.8 44.0 0
Debt Metrics
Total Debt 58.7 55.7 56.5 51.9 26.6 28.3 27.1 28.8 29.2 30.6 8.0 9.3 10.7 12.0 13.2 14.5 15.8 13.0 0 0 0 0 0 0 48.2 0 0
Net Debt (12.5) (191.2) (22.0) (32.3) (49.3) (81.7) (71.9) (88.0) (20.7) (24.0) (34.3) (49.6) (22.9) (52.5) (34.3) (27.0) (63.0) (67.5) (147.4) (188.2) (126.4) (119.4) (265.5) (159.3) (8.2) (34.8) 39.0
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Operating Activities
Net Income (87.2) (78.2) (86.4) (43.5) (56.4) (58.5) (49.0) (44.5) (41.5) (42.0) (37.0) (24.3) (40.7) (46.7) (45.7) (45.4) (42.5) (37.7) (28.8) (26.4) (24.3) (19.9) (18.5) 7.6 (12.4) (13.5) (2.4) (3.1) (2.7)
Depreciation & Amortization 3.8 4.6 5 5.1 4.1 4.3 4.1 4.1 3.9 3.8 3.4 3.3 3.2 3.0 2.9 2.6 2.3 4.0 0.7 0.6 0.6 0.6 0.6 0.5 0.5 0.5 0.6 0.6 0.6
Stock-Based Compensation 0 0 9.8 10.4 8.7 8.5 8.8 8.8 7.8 8.0 8.4 8.7 8.5 8.3 7.0 6.8 6.1 4.8 4.3 3.9 2.7 2.5 1.1 0.5 0.2 0.2 0.1 0.1 0.1
Change in Working Capital 3.9 (1.6) 16.5 (32.5) (14.0) 0.4 (2.7) (5.9) (10.2) 53.9 (14.8) (5.3) (18.6) (1.9) (10.6) 2.4 (9.0) (2.7) (6.9) (10.1) 28.8 (3.9) 10.6 (23.0) 52.7 0.1 38.1 (0.3) 0.6
Other Non-Cash Items 7.6 7.3 (2.2) (2.7) (3.6) (3.5) (3.4) (2.2) (2.9) 11.9 (1.2) (0.9) (0.8) (0.7) 0.1 0.7 0.5 0.6 0.7 0.3 0.2 0.1 0.1 0.0 0.0 (1.8) (0.0) (10.7) (8.3)
Operating Cash Flow (71.9) (67.8) (57.4) (63.2) (61.1) (48.8) (42.2) (39.7) (42.0) 26.7 (41.1) (18.5) (48.5) (38.0) (46.3) (32.9) (42.6) (30.9) (30.0) (31.5) 8.1 (20.5) (6.1) (14.4) 41.0 (12.7) 36.4 (13.3) (9.7)
Investing Activities
Capital Expenditure (1.0) (5.1) (2.7) (2.7) (3.5) (2.1) (2.3) (1.9) (2.9) (2.6) (2.5) (1.1) (2.3) (2.6) (3.4) (2.8) (3.5) (0.9) (1.9) (2.1) (0.8) (0.9) (1.7) (1.6) (0.4) (1.0) (0.5) (0.0) (0.2)
Acquisitions 0 0 0 0 0 0 38.4 0 (38.4) 88.5 (25.2) (44.9) (18.3) (57.6) 59.7 2.0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (255.9) (174.3) (103.0) (68.2) (110.2) (298.2) (129.8) (225.1) (54.8) (88.4) (74.6) (60.7) (22.6) (26.9) (132.4) (64.8) (15.2) (90.7) (74.6) (135.5) (47.7) (134.2) (111.4) (10.6) (19.1) (3.4) 0 0 0
Sales/Maturities of Investments 133.2 179.8 156.2 142.3 139.2 159.5 110.8 96.0 93.2 76.6 99.8 105.6 41.0 84.5 72.8 62.8 58.7 55.0 64.2 80.5 46.2 10.5 5.0 9.9 0 0 4 0 0
Other Investing Activities 0 0 0 0 0 0 (38.4) 0 38.4 (88.5) 25.2 44.9 18.3 57.6 (59.7) (2.0) 0 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow (123.8) 0.3 50.5 71.5 25.5 (140.8) (21.3) (131.1) 35.5 (14.4) 22.8 43.8 16.1 55.0 (63.1) (4.8) 40.0 (36.5) (12.2) (57.1) (2.4) (124.6) (108.1) (2.3) (19.4) (4.4) 3.5 10.0 (0.6)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0.0 (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) 0 0 0 (0.0) 0 (0.0) (0.0) 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 1.4 3.9 0 0 0 0 0 0 0 96.0 0 0 0 0 0 0 0 1.1 0 0 0 0 0 0
Financing Cash Flow 20.0 236.0 1.2 0.0 1.5 200.5 45.8 237.8 1.6 0.0 1.7 0.0 1.5 (0.1) 115.4 0.4 1.5 0.5 1.6 150.5 1.4 (1.1) 220.4 119.7 0.0 0.1 (0.0) 0.0 0.0
Cash Position
Net Change in Cash (175.8) 168.5 (5.8) 8.3 (34.1) 11.0 (17.7) 67.0 (4.8) 12.3 (16.7) 25.4 (30.9) 16.9 6.0 (37.2) (1.1) (66.9) (40.7) 61.8 7.0 (146.2) 106.2 102.9 21.6 (17.0) 39.9 (3.3) (10.3)
Cash at Beginning 247.9 79.4 85.2 76.8 110.9 99.9 117.7 49.8 54.6 42.3 59.9 34.5 65.4 48.5 42.4 79.7 80.8 147.7 188.4 126.6 119.5 265.7 159.5 56.6 35.0 52.0 12.1 15.5 25.8
Cash at End 72.2 247.0 79.4 85.2 76.8 110.9 99.9 116.8 49.8 54.6 43.2 59.9 34.5 65.4 48.5 42.4 79.7 80.8 147.7 188.4 126.6 119.5 265.7 159.5 56.6 35.0 52.0 12.1 15.5
Free Cash Flow (73.0) (73.0) (60.1) (65.8) (64.6) (50.9) (44.5) (41.6) (44.8) 24.1 (43.6) (19.5) (50.7) (40.5) (49.7) (35.7) (46.1) (31.8) (31.8) (33.6) 7.2 (21.4) (7.8) (16.0) 40.6 (13.7) 35.9 (13.4) (9.8)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Income Statement
Revenue 6.3 13.6 7.9 44.1 18.5 13.3 12.6 12.1 16.6 15.2 18.5 30.7 12.7 6.8 10.8 11.4 9.6 7.4 10.3 7.1 5.0 6.7 4.1 4.2 2.9 1.9 10.6 9.4 9.2
Gross Profit (77.9) 8.9 2.9 (34.0) (51.2) (53.9) (42.9) (36.8) (33.4) (34.6) (29.4) (15.1) (33.1) (39.3) (37.0) (36.1) (33.5) (29.1) (20.7) (18.9) (18.0) (13.8) (14.9) (10.0) (10.1) (11.0) (0.4) (1.3) (1.2)
Operating Income (92.5) (83.1) (91.4) (48.3) (62.9) (64.7) (54.6) (48.5) (45.2) (45.3) (40.0) (26.8) (43.0) (48.7) (46.7) (45.7) (42.7) (38.0) (29.0) (26.4) (24.5) (20.0) (19.2) (13.2) (12.6) (13.6) (2.6) (3.2) (2.9)
Net Income (87.2) (78.2) (86.4) (43.5) (56.4) (58.5) (49.0) (44.5) (41.5) (42.0) (37.0) (24.3) (40.7) (46.7) (45.7) (45.4) (42.5) (37.7) (28.8) (26.4) (24.3) (19.9) (18.5) 7.6 (12.4) (13.5) (2.4) (3.1) (2.7)
EPS (Diluted) -0.79 -0.82 -1.03 -0.52 -0.67 -0.75 -0.67 -0.71 -0.76 -0.77 -0.68 -0.40 -0.65 -0.77 -0.88 -1.00 -0.95 -0.85 -0.65 -0.60 -0.63 -0.51 -1.09 0.22 -0.60 -0.65 -0.12 -0.94 -0.85
Balance Sheet
Cash & Equivalents 71.2 247.0 78.4 84.3 75.9 110.0 99.0 116.8 49.8 54.6 42.3 59.0 33.6 64.5 47.6 41.5 78.8 80.5 147.4 188.2 126.4 119.4 265.5 159.3 56.4 34.8 (39.0)
Total Assets 636.1 688.1 522.5 591.6 615.0 669.3 513.6 511.0 312.7 355.6 308.2 350.6 370.2 416.8 459.3 394.3 437.7 476.8 493.1 518.0 396.7 396.3 411.9 213.3 88.8 44.0 0
Total Debt 58.7 55.7 56.5 51.9 26.6 28.3 27.1 28.8 29.2 30.6 8.0 9.3 10.7 12.0 13.2 14.5 15.8 13.0 0 0 0 0 0 0 48.2 0 0
Stockholders' Equity 480.9 538.7 372.3 447.6 480.9 527.0 376.9 370.7 168.7 200.5 233.8 259.9 274.1 303.7 342.5 266.7 305.9 342.3 375.2 398.2 270.1 290.3 307.6 106.6 (69.8) (57.7) 11.3
Cash Flow
Operating Cash Flow (71.9) (67.8) (57.4) (63.2) (61.1) (48.8) (42.2) (39.7) (42.0) 26.7 (41.1) (18.5) (48.5) (38.0) (46.3) (32.9) (42.6) (30.9) (30.0) (31.5) 8.1 (20.5) (6.1) (14.4) 41.0 (12.7) 36.4 (13.3) (9.7)
Capital Expenditure (1.0) (5.1) (2.7) (2.7) (3.5) (2.1) (2.3) (1.9) (2.9) (2.6) (2.5) (1.1) (2.3) (2.6) (3.4) (2.8) (3.5) (0.9) (1.9) (2.1) (0.8) (0.9) (1.7) (1.6) (0.4) (1.0) (0.5) (0.0) (0.2)
Free Cash Flow (73.0) (73.0) (60.1) (65.8) (64.6) (50.9) (44.5) (41.6) (44.8) 24.1 (43.6) (19.5) (50.7) (40.5) (49.7) (35.7) (46.1) (31.8) (31.8) (33.6) 7.2 (21.4) (7.8) (16.0) 40.6 (13.7) 35.9 (13.4) (9.8)